Adrian M. Duek

Beersheba, D 84105, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Immature Platelet Fraction as a Surrogate Marker of Thrombo-Inflammation in Hospitalized COVID-19 Patients.

Immature Platelet Fraction as a Surrogate Marker of Thrombo-Inflammation in Hospitalized COVID-19 Patients.

Journal: Life (Basel, Switzerland)

Published: November 02, 2025

STK405759 targets microtubules, modulates STAT1, and enhances ruxolitinib efficacy in myeloproliferative neoplasms.

STK405759 targets microtubules, modulates STAT1, and enhances ruxolitinib efficacy in myeloproliferative neoplasms.

Journal: American journal of cancer research

Published: August 27, 2025

Clonal hematopoiesis driver mutations: molecular mechanisms and clinical implications - inclusive fitness of pre-leukemic hematopoietic stem and progenitor cells through pro-inflammatory features of their progeny.

Clonal hematopoiesis driver mutations: molecular mechanisms and clinical implications - inclusive fitness of pre-leukemic hematopoietic stem and progenitor cells through pro-inflammatory features of their progeny.

Journal: Haematologica

Published: August 21, 2025

Clonal hematopoiesis driver mutations: molecular mechanisms and clinical implications - inclusive fitness of pre-leukemic hematopoietic stem and progenitor cells through pro-inflammatory features of their progeny.

Clonal hematopoiesis driver mutations: molecular mechanisms and clinical implications - inclusive fitness of pre-leukemic hematopoietic stem and progenitor cells through pro-inflammatory features of their progeny.

Journal: Haematologica

Published: August 21, 2025

Flax transposons: unraveling their impact on domestication and agronomic trait variation.

Flax transposons: unraveling their impact on domestication and agronomic trait variation.

Journal: Vavilovskii zhurnal genetiki i selektsii

Published: July 30, 2025

Fedratinib for the treatment of myelofibrosis: a critical appraisal of clinical trial and "real-world" data.

Fedratinib for the treatment of myelofibrosis: a critical appraisal of clinical trial and "real-world" data.

Journal: Blood cancer journal

Published: November 06, 2024

The IIIVmrMLM method uncovers new genetic variants associated with resistance to Fusarium wilt in flax.

The IIIVmrMLM method uncovers new genetic variants associated with resistance to Fusarium wilt in flax.

Journal: Vavilovskii zhurnal genetiki i selektsii

Published: September 08, 2024

Chickpea diversity driven by transposon insertion polymorpism.

Chickpea diversity driven by transposon insertion polymorpism.

Journal: Vavilovskii zhurnal genetiki i selektsii

Published: July 28, 2024

CML in the very elderly: the impact of comorbidities and TKI selection in a real-life multicenter study.

CML in the very elderly: the impact of comorbidities and TKI selection in a real-life multicenter study.

Journal: Annals of hematology

Published: March 01, 2024

Outcomes of Fedratinib in Routine Treatment of Ruxolitinib-Resistant or -Refractory Patients with Primary and Post-Polycythemia Vera or Essential Thrombocythemia Myelofibrosis: A Nationwide Retrospective Study.

Outcomes of Fedratinib in Routine Treatment of Ruxolitinib-Resistant or -Refractory Patients with Primary and Post-Polycythemia Vera or Essential Thrombocythemia Myelofibrosis: A Nationwide Retrospective Study.

Journal: Acta haematologica

Published: January 28, 2024

PROLONGED POST-COVID-19 ANEMIA

PROLONGED POST-COVID-19 ANEMIA

Journal: Harefuah

Published: March 14, 2023

Mitigating the interference of Daratumumab with immunofixation electrophoresis. A single-center experience using Hydrashift 2/4 kit.

Mitigating the interference of Daratumumab with immunofixation electrophoresis. A single-center experience using Hydrashift 2/4 kit.

Journal: The Israel Medical Association journal : IMAJ

Published: October 30, 2022

Showing 1-12 of 34

Last Updated: 09/26/2026